Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vitamin D in MS: A vitamin for 4 seasons.
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.
Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
A case with neuromyelitis optica mimicking Susac's syndrome.
Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Hearing statement in multiple sclerosis: a case control study using auditory brainstem responses and otoacoustic emissions.
Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis.
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial.
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital.
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
Therapeutic effet of phase ii enzyme inducers in experimental allergic encephalomyelitis (eae).
Practical medical applications of quantitative MR relaxometry.
Acute and subacute inflammation of the optic nerve and its sheath: clinical features in Chinese patients.
Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE.
Anthraquinone derivative O,O'-bis-(3'-iodopropyl)-1,4-dihidroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis.
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
T Cell Epitope Mapping of JC Polyoma Virus-Encoded Proteome Reveals Reduced T Cell Responses in HLA-DRB1*04:01+ Donors.
Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
Ten-year follow-up shows efficacy of Sanofi's MS drug Lemtrada
Pages
« first
‹ previous
…
241
242
243
244
245
246
247
248
249
…
next ›
last »